Aptorum Group Limited
APM
$5.28
-$0.20-3.65%
Headlines
4/13/2024
-
Ticker Report
3/27/2024
-
Ticker Report
3/19/2024
-
The Fly
3/19/2024
-
The Fly
3/12/2024
-
The Fly
3/12/2024
-
The Fly
3/8/2024
-
The Fly
3/8/2024
-
The Fly
3/7/2024
-
Seeking Alpha - Healthcare
3/7/2024
-
SeekingAlpha.com: All News
3/7/2024
-
The Fly
3/7/2024
-
The Fly
3/7/2024
-
Benzinga
3/6/2024
-
Benzinga
3/6/2024
-
SeekingAlpha.com: All News
3/6/2024
-
Seeking Alpha - Healthcare
3/6/2024
-
Business Wire
1/26/2024
-
Ticker Report
1/13/2024
-
Ticker Report
1/2/2024
-
Zolmax
12/26/2023
-
SeekingAlpha.com: All News
12/22/2023
-
Business Wire
12/21/2023
-
Business Wire
12/4/2023
-
Ticker Report
Filings
Friday, December 22, 2023
Friday, June 30, 2023
Week of Apr 22 and 26 (est)
Price History
Corporate Info
44 20 8092 9299
17 Hanover Square
London, W1S 1BN
London, W1S 1BN
Business Description
Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The...
more